MARKET

ICCC

ICCC

Immucell
NASDAQ
8.36
-0.02
-0.24%
Closed 16:09 05/13 EDT
OPEN
8.62
PREV CLOSE
8.38
HIGH
8.78
LOW
8.36
VOLUME
17.98K
TURNOVER
0
52 WEEK HIGH
9.08
52 WEEK LOW
4.520
MARKET CAP
75.63M
P/E (TTM)
-72.5694
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICCC last week (0504-0508)?
Weekly Report · 3d ago
ImmuCell Reaches Settlement Agreement with Norbrook Laboratories
TipRanks · 5d ago
ImmuCell And Norbrook Laboratories Reach Settlement Agreement, Norbrook To Pay $2M Following Expiration Of 2019 Supply Deal
Benzinga · 5d ago
IMMUCELL CORP - NORBROOK AGREES TO PAY IMMUCELL $2 MLN UNDER SETTLEMENT DEED - SEC FILING
Reuters · 5d ago
ImmuCell settles Norbrook dispute, receives $2 million payment
PUBT · 5d ago
ImmuCell publishes update to financial calendar
PUBT · 6d ago
Weekly Report: what happened at ICCC last week (0427-0501)?
Weekly Report · 05/04 10:22
Weekly Report: what happened at ICCC last week (0420-0424)?
Weekly Report · 04/27 10:25
More
About ICCC
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves. The Mastitis segment includes products called California Mastitis Test and Re-Tain. Re-Tain, a novel treatment for subclinical mastitis in dairy cows, is in the late stages of development. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing immediate immunity against each of the three causes of calf scours (E. Coli, coronavirus, and rotavirus).

Webull offers ImmuCell Corp stock information, including NASDAQ: ICCC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICCC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICCC stock methods without spending real money on the virtual paper trading platform.